David Good

David Good

Auto-generated profile, based on publicly available information

David Good

Division of Molecular and Gene Therapies, Griffith Health Institute and School of Medical Science, Griffith University, Gold Coast, QLD 4222, Australia

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
BYBinbin Yang
Binbin Yang
DGDavid Good
David Good
TMTamim Mosaiab
Tamim Mosaiab
WLWei Liu
Wei Liu
GNGuoying Ni
Guoying Ni
MWMing Wei
Ming Wei
LL‐37, also called cathelicidin, is an important part of the human immune system, which can resist various pathogens. A plethora of experiments have demonstrated that it has the multifunctional effects of immune regulation, in addition to antimicrobial activity. Recently, there have been increasing interest in its immune function. It was found that LL‐37 can have two distinct functions in different tissues and different microenvironments. Thus, it is necessary to investigate LL‐37 immune functions from the two sides of the same coin. On the one side, LL‐37 promotes inflammation and immune response and exerts its anti‐infective and antitumor effects; on the other side, it has the ability to inhibit inflammation and promote carcinogenesis. This review presents a brief summary of its expression, structure, and immunomodulatory effects as well as brief discussions on the role of this small peptide as a key factor in the development and treatment of various inflammation‐related diseases and cancers.

20 August 2018 in Toxins
Verified
Journal Article
Open access
PDF file
JQJi Qi
Ji Qi
AZAbu Hasanat Md Zulfiker
Abu Hasanat Md Zulfiker
CLChun Li
Chun Li
DGDavid Good
David Good
MWMing Wei
Ming Wei
Toxins from toads have long been known to contain rich chemicals with great pharmaceutical potential. Recent studies have shown more than 100 such chemical components, including peptides, steroids, indole alkaloids, bufogargarizanines, organic acids, and others, in the parotoid and skins gland secretions from different species of toads. In traditional Chinese medicine (TCM), processed toad toxins have been used for treating various diseases for hundreds of years. Modern studies, including both experimental and clinical trials, have also revealed the molecular mechanisms that support the development of these components into medicines for the treatment of inflammatory diseases and cancers. More recently, there have been studies that demonstrated the therapeutic potential of toxins from other species of toads, such as Australian cane toads. Previous reviews mostly focused on the pharmaceutical effects of the whole extracts from parotoid glands or skins of toads. However, to fully understand the molecular basis of toad toxins in their use for therapy, a comprehensive understanding of the individual compound contained in toad toxins is necessary; thus, this paper seeks to review the recent studies of some typical compounds frequently identified in toad secretions.

1 January 2014 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
JQJi Qi
Ji Qi
CTC K Tan
C K Tan
SHSaeed Mujahid Hashimi
Saeed Mujahid Hashimi
AZAbu Hasanat Md Zulfiker
Abu Hasanat Md Zulfiker
DGDavid Good
David Good
MWMing Wei
Ming Wei
Toad glandular secretions and skin extractions contain many natural agents which may provide a unique resource for novel drug development. The dried secretion from the auricular and skin glands of Chinese toad (Bufo bufo gargarizans) is named Chansu, which has been used in Traditional Chinese Medicine (TCM) for treating infection and inflammation for hundreds of years. The sterilized hot water extraction of dried toad skin is named Huachansu (Cinobufacini) which was developed for treating hepatitis B virus (HBV) and several types of cancers. However, the mechanisms of action of Chansu, Huachansu, and their constituents within are not well reported. Existing studies have suggested that their anti‐inflammation and anticancer potential were via targeting Nuclear Factor (NF)‐κB and its signalling pathways which are crucial hallmarks of inflammation and cancer in various experimental models. Here, we review some current studies of Chansu, Huachansu, and their compounds in terms of their use as both anti‐inflammatory and anticancer agents. We also explored the potential use of toad glandular secretions and skin extractions as alternate resources for treating human cancers in combinational therapies.

15 September 2019 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
WLWei Liu
Wei Liu
BYBinbin Yang
Binbin Yang
LYLu Yang
Lu Yang
JKJasmine Kaur
Jasmine Kaur
CJCalvin Jessop
Calvin Jessop
MWMing Wei
Ming Wei
Effective cancer therapy is one of the biggest global challenges. Conventional cancer therapies have been at the forefront of combating cancers, but more evidence showed considerable side effects, limiting their use. There are various new therapies in development, but combined approaches for treating cancer are much expected. Natural herbs had been traditionally in use for cancer therapy in most parts of the world. In this review, we have examined ten commonly used Chinese herbs that have, for centuries, shown effectiveness in treating cancers. They demonstrated the abilities to promote the apoptosis of cancer cells, inhibit their metastasis, activate the patient’s anticancer immunity, and synergistically increase the efficacy of conventional chemotherapy and radiation therapy when used in combination. Clinical experiences had proved that these herbs and their bioactive compounds were effective against a plethora of cancers through a variety of mechanisms, effectively improving patients’ quality of life without significant side effects. These advantages indicate that there are huge potentials in the development of Chinese herbs into cancer medicine as part of a promising, holistic cancer treatment modality.

1 January 2013 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
CLChun Li
Chun Li
SHSaeed Mujahid Hashimi
Saeed Mujahid Hashimi
SCSiyu Cao
Siyu Cao
AMAlbert Sleiman Mellick
Albert Sleiman Mellick
WDWei Duan
Wei Duan
MWMing Q. Wei
Ming Q. Wei
Chansu is one of the most widely used traditional Chinese medicines in China, Japan, and other Southeast Asian countries primarily for antipain, anti-inflammation, and recently anticancer. Over 10 recipes and remedies contained Chansu, which are easily available in pharmacies and hospitals, but the mechanisms of action were not clearly articulated. In the present study, Cinobufagin (CBF), the major compound of Chansu, was employed as a surrogate marker to determine its ability in inducing cancer cell death. As expected, CBF has significant cancer-killing capacity for a range of cancers, but such ability differs markedly. Colon and prostate cancers are more sensitive than skin and lung cancers. Interestingly, cancer cells die through apoptotic pathway either being biphasic caspase-3-dependent (HCT116) or independent (HT29). Multipathway analysis reveals that CBF-induced apoptosis is likely modulated by the hypoxia-inducing factor-1 alpha subunit (HIF-1α) as its inhibition was evidentin vitroandin vivo. Taken together, these results demonstrate that CBF is a potent apoptotic inducer with potential for further development as a novel and effective anticancer agent for a range of cancers, especially colon cancer.

1 January 1996 in South African Journal of Zoology
Verified
Journal Article
Open access
WBWilliam R. Branch
William R. Branch
ABAaron M. Bauer
Aaron M. Bauer
DGDavid A. Good
David A. Good
An analysis of morphological and allozyme variation in the Namaqua gecko, Pachydactylus namaquensis from southern Africa is presented. Three separately evolving lineages, well defined by morphology and allozyme variation, are identified. The isolated southern population, occurring on the southern escarpment and Cape Fold Mountains surrounding the western Little Karoo, is named P. kladamderma sp. nov., and is characterized by a slit-like ear opening, low number of granules bordering the mental (3-6) and mental and adjacent infralabials (513), the frequent (79%) occurence of the supralabial entering the nostril, and its drab brown base colouration. A northern population, occurring in southern Namibia and the Richtersveld is named P. haackei sp. nov., and is characterized by its more rounded or squared ear opening; high number of granules bordering the mental and adjacent infralabials (11-19), the general exclusion of the supralabial from the nostril (only 3.7% entry), and brighter, lighter colouration. It is further differentiated from P. kladaroderma on the basis of fixed differences at 11 allozyme loci. Both new species differ from P. namaquensis, which is mainly restricted to Little Namaqua- land, but is sympatric with P. haackei in the Lower Orange River region, by their more heterogenous dorsal scalation, smaller cloacal spurs, lack of spine-like tubercles on the lateral surfaces of the tail, and more fragile skin. The type locality of P. namaquensis is restricted to ‘the vicinity of Springbok, Little Namaqualand, Northern Cape Province, South Africa’.